Multiple Signals from Dysfunctional Mitochondria Activate the Pleiotropic Drug Resistance Pathway in Saccharomyces cerevisiae
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Multiple or pleiotropic drug resistance most often occurs in Saccharomyces cerevisiae due to substitution mutations within the Cys(6)-Zn(II) transcription factors Pdr1p and Pdr3p. These dominant transcriptional regulatory proteins cause elevated drug resistance and overexpression of the ATP-binding cassette transporter-encoding gene, PDR5. We have carried out a genetic screen to identify negative regulators of PDR5 expression and found that loss of the mitochondrial genome (rho(o) cells) causes up-regulation of Pdr3p but not Pdr1p function. Additionally, loss of the mitochondrial inner membrane protein Oxa1p generates a signal that results in increased Pdr3p activity. Both of these mitochondrial defects lead to increased expression of the PDR3 structural gene. Importantly, the signaling pathway used to enhance Pdr3p function in rho(o) cells is not the same as in oxa1 cells. Loss of previously described nuclear-mitochondrial signaling genes like RTG1 reduce the level of PDR5 expression and drug resistance seen in rho(o) cells but has no effect on oxa1-induced phenotypes. These data uncover a new regulatory pathway connecting expression of multidrug resistance genes with mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In S. cerevisiae, dysfunctional mitochondria activate the pleiotropic drug resistance pathway for adaptation (13).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is consistent with reports for S. cerevisiae which demonstrate that dysfunctional mitochondria send a signal to the nucleus via a retrograde signaling pathway that leads to the over expression of many genes, including the pleiotropic drug resistance transcriptional factors, PDR1 and PDR3 (21, 73).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The activation of PDR3 further leads to transcriptional induction of genes encoding multidrug resistance pumps, including PDR5 (an S. cerevisiae homolog of Candida CDR1) (2, 21, 51, 73).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [21]
In the citing paper
“Such hyperactivation can be caused by gain-of-function (GOF) mutations in PDR1 or PDR314,15 or mitochondrial dysfunction (e.g. loss of the mitochondrial genome), the latter of which only stimulates Pdr3-dependent gene expression16.”
From SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes (2022) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sikorski, R. S., & Hieter, P. (1989) · Genetics · doi:10.1093/genetics/122.1.19 · Cited by 8,664
Transformation of intact yeast cells treated with alkali cations
Ito, H., Fukuda, Y., Murata, K., & Kimura, A. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.163-168.1983 · Cited by 7,518
Sherman, F., Fink, G. R., & Hicks, J. B. (1979) · Cold Spring Harbor Laboratory eBooks · Cited by 7,430
Longtine, M. S., Mckenzie III, A., Demarini, D. J., Shah, N. G., Wach, A., Brachat, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10<953::aid-yea293>3.0.co;2-u · Cited by 5,345
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae
Wach, A., Brachat, A., Pöhlmann, R., & Philippsen, P. (1994) · Yeast · doi:10.1002/yea.320101310 · Cited by 2,531
Gichner, T. (1982) · Biologia Plantarum · doi:10.1007/bf02909099 · Cited by 1,181
Martínez-Pastor, M. T., Marchler, G., Schüller, C., Marchler-Bauer, A., Ruis, H., & Estruch, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00576.x · Cited by 1,076
[10] Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast
Guarente, L. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01013-7 · Cited by 1,071
Research works printed but not linked: 10
- 3. Grant, C.E. ∙ Valdimarsson, G. ∙ Hipfner, D.R. ... Cancer Res. 1994; 54:357-361 PubMed Google Scholar
- Katzmann, 1994, Mol. Cell. Biol., 14, 4653
- Gietz, 1995, Methods Mol. Cell Biol., 5, 255
- Wu, 1994, Mol. Cell. Biol., 14, 5832
- Tamai, 1994, Mol. Cell. Biol., 14, 8155
- Kim, 1986, Mol. Cell. Biol., 6, 1936
- Zhou, 1987, Gene, 15, 5261
- Friden, 1987, Mol. Cell. Biol., 7, 2708
- Johnston, 1987, Microbiol. Rev., 51, 458, 10.1128/mr.51.4.458-476.1987 · doi:10.1128/mr.51.4.458-476.1987 · Paper page
- Friden, 1989, Mol. Cell. Biol., 9, 4056
Cited by
Items 101–189 of 189
El Meouche, I., Jain, P., Jolly, M. K., & Capp, J.-P. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102069 · Cited by 22
“Regulatory pathways were already shown to connect dysfunctional mitochondria and expression of multidrug resistance genes and mitochondrial function in S. cerevisiae [71] and mitochondrial loss is also associated with acquisition of resistance to azole derivatives in C. glabrata [72,73].”
BackgroundSphingolipids and mitochondrial function in budding yeast
Spincemaille, P., Matmati, N., Hannun, Y. A., Cammue, B. P. A., & Thevissen, K. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.06.015 · Cited by 26
“Interestingly, the retrograde response is linked to SL homeostasis and multidrug resistance [31, 32, 85, 86].”
BackgroundJjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata
Whaley, S. G., Caudle, K. E., Simonicova, L., Zhang, Q., Moye-Rowley, W. S., & Rogers, P. D. (2018) · mSphere · doi:10.1128/msphere.00466-17 · Cited by 22
“Previous work had shown that Pdr3 is activated in mitochondrion-deficient mutants (29).”
BackgroundRPD3 and ROM2 are required for multidrug resistance in Saccharomyces cerevisiae
Borecká, S., Kozovská, Z., Hikkel, I., Džugasová, V., & Šubík, J. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2007.00352.x · Cited by 21
“Saccharomyces cerevisiae cells that have lost their mitochondrial genome strongly induce a Pdr3p-dependent transcription of multidrug resistance genes and display lower susceptibility to drugs as the wild-type cells (Hallstrom & Moye-Rowley, 2000).”
BackgroundKołaczkowska, A., Manente, M., Kołaczkowski, M., Laba, J., Ghislain, M., & Wawrzycka, D. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00768.x · Cited by 21
Activation of the mitochondrial signaling pathway in response to organic solvent stress in yeast
Nishida‐Aoki, N., Mori, H., Kuroda, K., & Ueda, M. (2014) · Current Genetics · doi:10.1007/s00294-014-0463-9 · Cited by 20
Koh, J. Y., Hájek, P., & Bedwell, D. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7576-7586.2001 · Cited by 24
“Recently, the PDR pathway was also reported to play a role in monitoring the functional status of mitochondria (22).”
BackgroundInfluentialRetrograde Signaling as a Mechanism of Yeast Adaptation to Unfavorable Factors
Trendeleva, T. A., & Zvyagilskaya, R. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918020025 · Cited by 21
Vijayraghavan, S., Kozmin, S. G., Strope, P. K., Skelly, D. A., Lin, Z., Kennell, J. C., Magwene, P. M., Dietrich, F. S., & McCusker, J. H. (2018) · Genetics · doi:10.1534/genetics.118.301546 · Cited by 18
“Specifically, the Hasegawa– Kishino–Yano model (Hasegawa et al. 1985) was used for ATP6 and the Tamura 3-parameter model (Tamura 1992) 774 S. Vijayraghavan et al. was used for ENS2.”
MethodPenetrating cations induce pleiotropic drug resistance in yeast
Galkina, K. V., Besedina, E. G., Zinovkin, R. A., Severin, F. F., & Кнорре, Д. А. (2018) · Scientific Reports · doi:10.1038/s41598-018-26435-z · Cited by 17
Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata
Pais, P., Galocha, M., & Teixeira, M. C. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_7 · Cited by 18
van Leeuwen, J. S., Vermeulen, N. P. E., & Vos, J. C. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00253-11 · Cited by 17
“a kind gift from Scott Moye-Rowley (8, 16, 21, 38).”
BackgroundInfluentialELM1 Is Required for Multidrug Resistance in Saccharomyces cerevisiae
Souid, A., Gao, C., Wang, L., Milgrom, E. M., & Shen, W.-C. W. (2006) · Genetics · doi:10.1534/genetics.106.057596 · Cited by 18
Nikolov, V. N., Malavia, D., & Kubota, T. (2022) · Nature Communications · doi:10.1038/s41467-022-29591-z · Cited by 16
Comparative Functional Genomics of Stress Responses in Yeasts
Lelandais, G., & Devaux, F. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0029 · Cited by 16
“, 2000), together with global genetic screens (Hallstrom and Moye-Rowley, 2000), identified a new functional connection between PDR and the mitochondrial oxidative phosphorylation, which was shown to be specific of Pdr3 (Fig.”
Rhoads, D. M., & Vanlerberghe, G. C. (2004) · Advances in photosynthesis and respiration · doi:10.1007/978-1-4020-2400-9_5 · Cited by 17
Taylor, M. B., Skophammer, R. G., Warwick, A. R., Geck, R. C., Boyer, J. M., Students, Y., Walson, M., Large, C. R. L., Hickey, A. S.-M., Rowley, P. A., et al. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac246 · Cited by 15
Cross-feeding affects the target of resistance evolution to an antifungal drug
Durand, R., Jalbert-Ross, J., Fijarczyk, A., Dubé, A. K., & Landry, C. R. (2023) · PLOS Genetics · doi:10.1371/journal.pgen.1011002 · Cited by 14
Protonophore FCCP provides fitness advantage to PDR-deficient yeast cells
Galkina, K. V., Finkelberg, J. M., Маркова, О. В., Azbarova, A. V., Banerjee, A., Kumari, S., Соколов, С. С., Severin, F. F., Prasad, R., & Кнорре, Д. А. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09849-1 · Cited by 15
Steier, Z., Vermitsky, J.-P., Toner, G., Gygax, S. E., Edlind, T., & Katiyar, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02394-12 · Cited by 14
“cerevisiae petite mutants, PDR5 upregulation is mediated at least in part by the retrograde (mitochondrion-to-nucleus) signaling components Rtg1, a transcription factor, and Rtg2, a component of the SLIK histone acetyltransferase complex (25, 26).”
BackgroundInfluentialLu, Z., Jia, X., Chen, Y., Han, X., Chen, F., Tian, S., Su, X., Li, Z., Zhao, J., Zhang, X., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01659-17 · Cited by 16
Azbarova, A. V., Galkina, K. V., Sorokin, M., Severin, F. F., & Кнорре, Д. А. (2017) · Scientific Reports · doi:10.1038/s41598-017-13576-w · Cited by 14
Phospholipid biosynthesis disruption renders the yeast cells sensitive to antifungals
Kundu, D., Hameed, S., Fatima, Z., & Pasrija, R. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00713-3 · Cited by 14
Yamada, Y. M. A. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02373-1 · Cited by 13
“The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3.”
BackgroundInfluentialAntifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 15
Impact of mitochondrial function on yeast susceptibility to antifungal compounds
Šarinová, M., Tichá, E., Obernauerova, M., & Gbelská, Y. (2007) · Folia Microbiologica · doi:10.1007/bf02931302 · Cited by 13
Do Multiple Drug Resistance Transporters Interfere with Cell Functioning under Normal Conditions?
Кнорре, Д. А., Galkina, K. V., Широковских, Т. С., Banerjee, A., & Prasad, R. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920120081 · Cited by 13
Organelle Communication with the Nucleus
Sengupta, S., & Levy, D. L. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-62036-2_1 · Cited by 11
Mutlu, N., Garipler, G., Akdoğan, E., & Dunn, C. D. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.114.010330 · Cited by 11
Tuning the Sensitivity of the PDR5 Promoter-Based Detection of Diclofenac in Yeast Biosensors
Schuller, A., Rödel, G., & Ostermann, K. (2017) · Sensors · doi:10.3390/s17071506 · Cited by 12
“Pdr1p and Pdr3p belong to a family of zinc cluster proteins that also includes Stb5p, Rdr1p, Yrr1p, and Pdr8p, some of which possess overlapping or identical binding sites with Pdr1p/Pdr3p [13].”
BackgroundInfluentialCallegari, S., McKinnon, R. A., Andrews, S., & Lopes, M. D. B. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.022 · Cited by 11
“This possibly indicates a hyperactive retrograde response, which increases the activity of multidrug resistance pumps [32].”
BackgroundPaul, S. K., McDonald, W. H., & Moye-Rowley, S. (2018) · Molecular Microbiology · doi:10.1111/mmi.14109 · Cited by 11
Sidorova, M., Drobná, E., Džugasová, V., Hikkel, I., & Šubík, J. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00174.x · Cited by 11
“The pdr3 mutant alleles suppress drug resistance in gain-of-function pdr1 and pdr3 mutants Gain-of-function mutations in either the PDR1 or PDR3 genes increase the resistance of yeast mutants to several antifungals (Carvajal et al., 1997; Nourani et al., 1997; Simonics et al., 2000).”
BackgroundInfluentialGray, C. H., Borges-Walmsley, M. I., Evans, G. J. S., & Walmsley, A. R. (2003) · Yeast · doi:10.1002/yea.1013 · Cited by 14
ABC Transporters of Pathogenic Fungi: Recent Advances in Functional Analyses
Niimi, M., Tanabe, K., Wada, S.-I., Yamazaki, A., Uehara, Y., Niimi, K., Lamping, E., Holmes, A. R., Monk, B. C., & Cannon, R. D. (2005) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.46.249 · Cited by 10
Zhu, X., Cai, J., Zhou, F., Wu, Z., Li, D., Li, Y., Xie, Z., Zhou, Y., & Liang, Y. (2018) · Traffic · doi:10.1111/tra.12611 · Cited by 9
“Loss of the mitochondrial genome to form petite cells activates the pleiotropic drug resistance pathway via overexpression of PDR5, encoding an ATP-binding cassette transporter.(28) Upregulation of PDR5 in petite mutants depends on the presence of PDR3.”
BackgroundGeck, R. C., Moresi, N. G., Anderson, L., Students, Y., Addepalli, I., Aggarwal, D., Agnihotri, P., Ali, A. A., Amorosi, C. J., Anand, A., et al. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae148 · Cited by 9
“…frequently selected for in both caffeine and clo-trimazole, confirming previous reports that mtDNA loss increases growth in the presence of azoles and caffeine, at least partly by increased Pdr3 activity (Bard et al. 1980; Hallstrom and Moye-Rowley 2000; Ferrari et al. 2011; Taylor et al. 2022).”
BackgroundPhysiological functions of multidrug transporters in yeast
Prasad, R., & Panwar, S. L. (2004) · Cited by 14
Litvinchuk, A., Соколов, С. С., Rogov, A. G., Маркова, О. В., Кнорре, Д. А., & Severin, F. F. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.02.001 · Cited by 10
“Dysfunction of mitochondria is known to be inducer of a retrograde response signaling pathway that subsequently activates multidrug resistance pumps (Hallstrom and Moye-Rowley, 2000).”
BackgroundAntifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_30 · Cited by 10
Chow, E. W. L., Song, Y., Wang, H., Xu, X., Gao, J., & Wang, J. (2024) · Molecular Microbiology · doi:10.1111/mmi.15229 · Cited by 8
Akdoğan, E., Tardu, M., Garipler, G., Baytek, G., Kavaklı, İ. H., & Dunn, C. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146511 · Cited by 8
“Furthermore, the pleiotropic drug resistance (PDR) pathway can be induced by mtDNA loss [38], as is the expression of several tricarboxylic acid cycle enzymes via activation of the yeast retrograde (RTG) pathway [39,40].”
BackgroundCaffeine-tolerant mutations selected through an at-home yeast experimental evolution teaching labPreprint
Moresi, N. G., Geck, R. C., Skophammer, R. G., Godin, D., Students, Y., Taylor, M. B., & Dunham, M. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.17.524437 · Cited by 8
Candida auris vacuolar calcium pump mediates fluconazole efflux and resistance evolution
Song, Y., Chen, J., Wan, J., Zhang, J., Liu, Q., Sun, F., Zhang, H., Guo, Y., Chow, E. W. L., Chen, Y., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02270-1 · Cited by 8
FUNGAL ABC PROTEINS IN CLINICAL DRUG RESISTANCE AND CELLULAR DETOXIFICATION
BAUER, B. E., Schüller, C., & Kuchler, K. (2003) · Elsevier eBooks · doi:10.1016/b978-012352551-2/50016-0 · Cited by 7
Buechel, E. R., & Pinkett, H. W. (2023) · FEBS Letters · doi:10.1002/1873-3468.14762 · Cited by 6
“The PDR network, involved in multidrug resistance in yeast, is also triggered by a variety of general stresses including mitochondrial damage, heat shock, membrane damage, and translational stress [25 – 28].”
BackgroundGolin, J. E., & Schmitt, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101010 · Cited by 6
Druseikis, M. E., Mottola, A., & Berman, J. G. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00189-3 · Cited by 6
“cerevisiae, loss of mitochondrial DNA is associated with increased drug resistance [18, 19].”
BackgroundyEvo: A modular eukaryotic genetics and evolution research experience for high school students
Taylor, M. B., Warwick, A. R., Skophammer, R. G., Boyer, J. M., Geck, R. C., Gunkelman, K., Walson, M., Rowley, P. A., & Dunham, M. J. (2024) · Ecology and Evolution · doi:10.1002/ece3.10811 · Cited by 5
“One route to clotrimazole resistance involves loss of cellular respira - tion (by mutations in the mitochondrial genome; Hallstrom & Moye-Rowley, 2000 ).”
BackgroundGenetic landscape of an in vivo protein interactome
Besse, S., Sakaguchi, T., Gauthier, L., Sahaf, Z., Ravindran, R., González, L., Castellanos-Girouard, X., Clermont, C., Kocatuğ, N., Péloquin, O., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02747-z · Cited by 5
Retrograde signaling: A novel antifungal drug target
Fatima, Z., Kumar, B., Rehman, S., & Hameed, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820528-0.00015-6 · Cited by 4
Yamada, Y. M. A. (2022) · Microorganisms · doi:10.3390/microorganisms10030601 · Cited by 5
“Notably, Pdr3, but not Pdr1, is required for the induction of PDR5 expression in ρ0 cells [10,24].”
BackgroundMöller-Hergt, B. V., Carlström, A., Suhm, T., & Ott, M. (2018) · Cells · doi:10.3390/cells7100172 · Cited by 4
“However, it was shown that disruption of the OXA1 insertase causes a multiple drug resistance [27].”
BackgroundManzoor, Y., Aouida, M., Ramadoss, R., Moovarkumudalvan, B., Ahmed, N., Sulaiman, A. A., Mohanty, A., Ali, R., Mifsud, B., & Ramotar, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303747 · Cited by 3
Friis, R. M. N., & Schultz, M. C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.029 · Cited by 3
Mitochondrial Biogenesis: MitoCPR Resuscitates Import-Defective Mitochondria
Pires, J., & Haynes, C. M. (2018) · Current Biology · doi:10.1016/j.cub.2018.04.094 · Cited by 3
Recent Advances in Azole Based Scaffolds as Anticandidal Agents
Gurubasavaraj, P. M., & Charantimath, J. S. (2018) · Letters in Drug Design & Discovery · doi:10.2174/1570180815666180917125916 · Cited by 3
Candida glabrata Hst1-Rfm1-Sum1 complex evolved to control virulence-related genes
Vázquez-Franco, N., Gutiérrez‐Escobedo, G., Juárez‐Reyes, A., Orta‐Zavalza, E., Castaño, I., & Peñas, A. D. L. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103656 · Cited by 3
Unveiling the roles of CaSDH8 in Candida albicans : Implications for virulence and azole resistance
Huang, M., Song, D., Zhou, L., Jiao, Z., Yang, L., Yang, Y., Peng, J., & Guo, G. (2024) · Virulence · doi:10.1080/21505594.2024.2405000 · Cited by 3
“Earlier studies in S. cerevisiae have revealed that the inhibitory effect of FLC requires the presence of well-functioning mitochondria [53,54].”
BackgroundABC Transporters in Yeast – Drug Resistance and Stress Response in a Nutshell
Kuchler, K., & Schüller, C. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6_11 · Cited by 3
Decreased susceptibility to antifungals in respiratory-deficientKluyveromyces lactis mutants
Šarinová, M., Straková, V., Balková, K., & Gbelská, Y. (2007) · Folia Microbiologica · doi:10.1007/bf02932108 · Cited by 4
Ostojić, J., Glatigny, A., Herbert, C. J., Dujardin, G., & Bonnefoy, N. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.004 · Cited by 2
Funasaka, M., Ota, M., & Yamada, Y. M. A. (2024) · Microbiology Research · doi:10.3390/microbiolres15020048 · Cited by 2
“…DNA in C. glabrata cells results in increased expression of multidrug resistance genes, including CgCDR1 , and increased PDR. Pdr3 but not Pdr1 is strongly activated in S. cerevisiae ρ 0/ − cells; therefore, the transcription of ABC transporter genes such as PDR5 and PDR is hyperactivated [27].”
BackgroundMitochondrial dysfunction enhances Gal4-dependent transcription
Jeličić, B., Traven, A., Filić, V., & Sopta, M. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.033 · Cited by 3
“Additionally, mitochondrial dysfunction has been shown to change transcription of the rRNA genes and genes encoding enzymes of the TCA cycle [20,21], convert the corepressor Tup1/Ssn6 to a coactivator of transcription [22] and increase the activity of Pdr3, a yeast transcription factor involved in pleiotropic drug res…”
BackgroundRole of Mitochondria in Generation of Phenotypic Heterogeneity in Yeast
Dhar, R. (2020) · Journal of the Indian Institute of Science · doi:10.1007/s41745-020-00176-3 · Cited by 2
Transcriptional Regulation of Azole Antifungal Resistance and Tolerance in Candida Glabrata
Caudle, K. E. (2010) · doi:10.21007/etd.cghs.2010.0045 · Cited by 4
“Cells that have lost their mitochondrial genome (known as petite mutants and designated “ρ”) strongly induce levels of ScPDR5 in a ScPdr3p-dependent manner (81).”
BackgroundGim3 buffers and potentiates de novo mutations that affect fluconazole susceptibility in yeast
Tawfeeq, M. T., Konstantinidis, D., Iraizos, A. L. R., Genechten, W. V., Vreys, J., Vermeersch, L., Voordeckers, K., Dijck, P. V., & Verstrepen, K. J. (2026) · EMBO Reports · doi:10.1038/s44319-026-00702-x · Cited by 1
“Mitochondrial dysfunction activates Pleiotropic Drug Resistance (PDR) regulators, increasing ef fl ux and modulating azole response (Ferrari et al, 2009; Tsai et al, 2006; Hallstrom and Moye-Rowley, 2000).”
Leuenberger, D., Curran, S. P., & Koehler, C. M. (2007) · Springer eBooks · doi:10.1007/0-387-26867-7_8 · Cited by 1
Site‐directed mutagenesis of Asp853 in Pdr3p transcriptional activator from Saccharomyces cerevisiae
Džugasová, V., Borecká, S., Batova, M., Pilišiová, R., Hervay, N. T., & Šubík, J. (2010) · Yeast · doi:10.1002/yea.1751 · Cited by 1
Bet Hedging in Pdr5-mediated Drug Resistance and a Mechanism for its Regulation
Azizi, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-6494 · Cited by 2
“Second, it has been long discovered that Pdr3 becomes active upon mitochondrial genome loss, resulting in high Pdr5 expression and drug-independent drug resistance, in ρ yeast cells [144,145], but the mechanism of such activation has remained unresolved.”
BackgroundSchwarzmüller, T., Klein, C., Valachovič, M., Glaser, W., & Kuchler, K. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627424.ch6
Miguel, C. M. (2012) · InTech eBooks · doi:10.5772/32603
“In this context, it is also important to point out the specific role of Pdr3, but not of Pdr1, in the response to mitochondrial dysfunction (Devaux et al. 2002; Hallstrom and Moye-Rowley 2000), one of the main natural sources of oxidative imbalance.”
BackgroundSánchez, M. E. G. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.122970
Proteomic analysis of mitochondrial proteins in doxorubicin-resistant cancer cells
Lo, Y., Chan, H., & Chou, H. (2012) · Genomic Medicine Biomarkers and Health Sciences · doi:10.1016/j.gmbhs.2012.04.008
White, C. (2009) · Syracuse University Libraries (Syracuse University)
Signaling Pathways from Mitochondria to the Nucleus
Liu, Z., & Butow, R. A. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50688-4
Sun, N. (2013) · DigitalGeorgetown (Georgetown University Library)
Type B trichothecenes-the relationship between slight structural changes and toxicity
Suzuki, T., & Iwahashi, Y. (2016) · JSM Mycotoxins · doi:10.2520/myco.66.45
Role of Mitochondria in Fungal Drug Resistance
Pasrija, R., & Kundu, D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9449-3_8
Pathogenesis of Fungal Infections and Drug-Resistance Phenomenon
Pola, S., Vijayaramya, A., Sanapala, P., & Deepthi, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-1695-5_17
Кнорре, Д. А., Galkina, K. V., Широковских, Т. С., Банерджи, A., & Prasad, R. (2020) · Biochemistry (Moscow) · doi:10.31857/s0320972520120088
(2001) · Yeast · doi:10.1002/yea.684
Yibmantasiri, P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17003284
Zhang, H., Zhu, Z., Gong, X., Cheng, W., Liao, W., Ma, T., Hu, Q., Li, L., Dun-zhu, Z.-X., Drol-ga, L.-Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5441096/v1
Antimykotische Zielstrukturen in Aspergillus fumigatus
Geißel, B. (2024) · doi:10.5282/edoc.33959
Buechel, E. R., & Pinkett, H. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.11.553033
“Conditions that increase Pdr3p expression, like loss of normal mitochondrial function, would likely reveal occupancy of additional sites that align with the known Pdr3p regulon(18).”
BackgroundBovier, E. (2012) · theses.fr (ABES) · doi:10.70675/c0bf4847z7148z4228z9304zd82d451ddc5c · Cited by 2
Malta-Luís, C., Romeo, G., Francescato, G., Mariano, C. V., Mil‐Homens, D., Petronilho, A., & Pimentel, C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00759-26
Metadata
- Authors
- Hallstrom, T. C., & Moye-Rowley, W. S.
- Affiliations
- University of Iowa (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 48
- Pages
- 37347-37356
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999757563
- Cited by
- 194
- References
- 61
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 10 · 2023: 9 · 2022: 3 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 16 · 2017: 5 · 2016: 6 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7244 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM049825, GM49825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- pleiotropic drug resistance, Pdr1p, PDR5, ABC transporters, mitochondrial dysfunction, Saccharomyces cerevisiae, transcriptional regulation, multidrug resistance genes
- MeSH terms
- Base Sequence, Drug Resistance, Microbial, Genes, Fungal, Membrane Proteins, Mitochondria, Saccharomyces cerevisiae, Signal Transduction, DNA Primers, ATP-Binding Cassette Transporters, Saccharomyces cerevisiae Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.